As Executive Vice President and Chief Digital & Technology Officer of Pfizer, Lidia Fonseca leads the company's digital transformation efforts—from drug development to manufacturing through commercialization. She spearheads an impressive enterprise-wide strategy that modernizes processes in every part of the business while delivering tangible results. Lidia and her team are dedicated to amplifying innovativeness at Pfizer through automating operational processes and infusing data, sophisticated analytics, as well as AI-driven insights for more efficient decision making. With the interconnection between digital information and healthcare continuing to grow, Lidia is driving the way forward by introducing novel Digital Health products such as their Digital Companion™ series of items which help amplify patient–doctor collaboration.
Under her strong guidance during the unprecedented COVID-19 pandemic, Pfizer launched Cominarty - a vaccine in an astonishingly short period of just one year alongside Paxlovid, an oral treatment. Not to mention that she was instrumental in automating over 90% of 100 million transactional processes across the company and launching the prestigious Pfizer Learning Academy! These are some accomplishments that truly define her success as a leader. She has accumulated a number of prestigious accolades, including being named on the 2022 Forbes CIO Next List for her role in revolutionizing technology leadership and spearheading groundbreaking innovation.